Lefty is a member of transforming growth factor-beta (TGF-β) superfamily and a potent antagonist of the TGF-β/Nodal/Activin signaling pathway. Lefty is critical in sustaining self-renewal/pluripotency status, and implicated in the differentiation of embryonic stem cells (ESCs). However, emerging studies depict Lefty as a multifaceted protein involved in myriad cellular events. Lefty proteins (human Lefty A and B) are secreted glycoproteins, but their mode of secretion and the significance of their “glycan” moiety remain mostly unexplored. By employing an in vitro system of human ESCs (hESCs), we observed that Lefty protein(s) are encased in exosomes for extracellular release. The exosomal- and cell-associated Lefty diverge in their proteolytic processing, and possess N-glycan structures of high mannose and complex nature. Differentiation of hESCs to mesenchymal cells (MSCs) or neuronal progenitor cells (NPCs) entails distinct changes in the Lefty A/Lefty B gene(s), and protein expression. Specifically, the proteolytic cleavage and N-glycan composition of the cell-associated and exosomal Lefty differ in the differentiated progenies. These modifications affected Lefty's inhibitory effect on Nodal signaling in aggressive melanoma cells. The microheterogeneity in the processing and glycosylation of Lefty protein(s) between hESCs, MSCs, and NPCs could present efficient means of diversifying the endogenous functions of Lefty. Whether Lefty's diverse functions in embryonic patterning, as well as its diffusion range in the extracellular environment, are similarly affected remains to be determined. Our studies underscore the potential relevance of Lefty-packaged exosomes for combating debilitating diseases such as cancer.
Get full access to this article
View all access options for this article.
References
1.
WangY-C, PetersonSE and LoringJF. (2014). Protein post-translatiomnal modificatios, and regulation of pluripotency in human stem cells. Cell Res, 24:143–160.
2.
HendersonJK, DraperJS, BaillieHS, FishelS, ThomsonJA, MooreH and AndrewsPW. (2002). Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells, 20:329–337.
3.
MenoC, ItoY, SaijohY, MatsudaY, TashiroK, KuharaS and HamadaH. (1997). Two closely-related left-right asymmetrically expressed genes, lefty-1 and lefty-2: their distinct expression domains, chromosomal linkage and direct neuralizing activity in Xenopus embryos. Genes Cells, 2:513–524.
4.
KothapalliR, BuyuskalI, WuS-Q, CheginiN and TabibzadehS. (1997). Detection of ebaf a novel human gene of TGF-β superfamily: association of gene expression with endometrial bleeding. J Clin Invest, 99:2342–2350.
5.
YashiroK, SaijohY, SakumaR, TadaM, TomitaN, AmanoK, MatsudaY, MondenM, OkadaS and HamadaetH. (2000). Distinct transcriptional regulation and phylogenetic divergence of human LEFTY genes. Genes Cells, 5:343–357.
6.
SpergerJM, ChenX, DraperJS, AntosiewiczJE, ChonCH, JonesSB, BrooksJD, AndrewsPW, BrownPO and ThomsonJA. (2003). Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Nat Acad Sci U S A, 100:13350–13355.
7.
AdjayeJ, HuntrissJ, HerwigR, BenKahlaA, BrinkTC, WierlingC, HultschigC, GrothD, YaspoML, et al. (2005). Primary differentiation in the human blastocyst: comparative molecular portraits of inner cell mass and trophectoderm cells. Stem Cells, 23:1514–1525.
8.
VallierL, AlexanderM and PedersenRA. (2005). Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci, 118:4495–4509.
9.
JamesD, LevineAJ, BesserD and Hemmati-BrivanlouA. (2005). TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development, 132:1273–1282.
10.
DvashT, SharonN, YanukaO and BenvenistyN. (2007). Molecular analysis of LEFTY-expressing cells in early human embryoid bodies. Stem Cells, 25:465–472.
11.
TabibzadehS and Hemmati-BrivanlouA. (2006). Lefty at the cossroads of “stemness” and differentiative events. Stem Cells, 24:1998–2006.
12.
FathiA, HatamiM, HajihosseiniV, FattahiF, KianiS, BaharvandH and SalekdehGH. (2011). Comprehensive gene expression analysis of human embryonic stem cells during differentiation into neural cells. PLoS One, 6:e22856.
13.
TangM, MikhailikA, PauliI, GiudiceLC, FazelabasAT, TulacS, CarsonDD, KaufmanDG, BarbierC, CreemersJW and TabibzadehS. (2005). Decidual differentiation of stromal cells promotes proprotein Convertase 5/6 expression and Lefty processing. Endocrinology, 146:5313–5320.
14.
WestmorelandJJ, TakahashiS and WrightCVE. (2007). Xenopus Lefty requires proprotein cleavage but not N-linked glycosylation to inhibit Nodal signaling. Dev Dynam, 236:2050–2061.
15.
PanBT, TengK, WuC, AdamM and JohnstoneRM. (1985). Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol, 101:942–948.
16.
TettaC, GhigoE, SilengoL, DeregibusMC and CamussiG. (2013). Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine, 44:11–19.
17.
GangodaL, BoukourisS, LiemM, KalraH and MathivananS. (2015). Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic?. Proteomics, 15:260–271.
18.
LawsonC, VicencioJM, YellonDM and DavidsonSM. (2016). Microvesicles and exosomes: new players in metabolic and cardiovascular disease. J Endocrinol, 228:R57–R71.
19.
RaposoG and StoorvogelW. (2013). Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol, 200:373–383.
20.
WolfersJ, LozierA, RaposoG, RegnaultA, ThéryC, MasurierC, FlamentC, PouzieuxS, FaureF, et al. (2001). Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med, 7:297–303.
21.
AndreF, ChaputN, SchartzNE, FlamentC, AubertN, BernardJ, LemonnierF, RaposoG, EscudierB, et al. (2004). Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol, 172:2126–2136.
22.
MeloSA, LueckeLB, KahlertC, FernandezAF and SethT. (2015). Glypican-1 identifies cancer exosomes and detects early pacreatic cancer. Nature, 523:177–182.
23.
SimpsonDL, WehmanB, GalatY, SharmaS, MishraR, GalatV, KaushalS. (2014). Engineering patient-specific valves using stem cells generated from skin biopsy specimens. Ann Thorac Surg, 98:947–954.
24.
MalchenkoS, XieJ, de Fatima BonaldoM, VaninEF, BhattacharyyaBJ, BelmadaniA, XiG, GalatV, GoossensW, et al. (2014). Onset of rosette formation during spontaneous neural differentiation of hESC and hiPSC colonies. Gene, 534:400–407.
25.
TheryC, ClaytonA, AmigorenaS and RaposoG. (2006). Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol Chapter, 3:Unit 3.22.
26.
CostaFF, SeftorEA, BischofJM, KirschmannDA, StrizziL, ArndtK, BonaldoMF, SoaresMB and HendrixMJC. (2009). Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment. Epigenomics, 1:387–398.
27.
UlloaL, CreemersJWM, RoyS, LiuS, MasonJ and TabibzadehS. (2001). Lefty proteins exhibit unique processing and activate the MAPK pathway. J Biol Chem, 276:21387–21396.
28.
SakumaR, OhnishiY, MenoC, FujiiH, JuanH, TakeuchiJ, OguraT, LiE, MiyazonoK and HamadaH. (2002). Inhibition of Nodal signaling by Lefty mediated through interaction with common receptors and efficient diffusion. Genes Cells, 7:401–412.
29.
FarinaA, D'AnielloC, SeverinoV, HochstrasserDF, ParenteA, MinchiottiG and ChamberyA. (2011). Temporal proteomic profiling of embryonic stem cell secretom during cardiac and neuronal differentiation. Proteomics, 11:3972–3982.
30.
ZhangHG, LiuC, SuK, ZhangL, ZhangS, WangJ, CaoX, GrizzleW and KimberlyRP. (2006). A membrane form of TNF-alpha presented by exosomes delays T cell activation-induced cell death. J Immunol, 176:7385–7393.
31.
SandersonMP, KellerS, AlonsoA, RiedleS, DempseyPJ and AltevogtP. (2008). Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion. J Cell Biochem, 103:1783–1797.
32.
SeelenmeyerC, StegmayerC and NickelW. (2008). Unconventional secretion of fibroblast growth factor 2 and galectin-1 does not require shedding of plasma membrane-derived vesicles. FEBS Lett, 582:1362–1368.
33.
WebberJ, SteadmanR, MasonMD, SteadmanR, MasonMD, TabiZ and ClaytonA. (2010). Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res, 70:1–10.
34.
NeubergerA and Marshall.RD (1968). Aspects of the structure of glycoproteins. In: Symposium on Foods—Carbohydrates and Their Roles. SchultzHW, CainRF, WrolstadRW, eds. Avi Publishing Co., Westport, CT, pp 115–132.
35.
KornfeldR and KornfeldS. (1985). Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem, 54:631–664.
36.
DvashT, MaysharY, DarrH, McElhaneyM, BarkerD and YanukaO. (2004). Temporal gene expression during differentiation of human embryonic stem cells and embryoid bodies. Human Repro, 19:2875–2883.
37.
KimDK, ChaY, AhnHJ, KimG and ParkKS. (2014). Lefty1 and lefty2 control the balance between self-renewal and pluripotent differentiation of mouse embryonic stem cells. Stem Cells Dev, 23:457–466.
38.
van BoxtelAL, ChesebroJE, HeliotC, RamelMC, StoneRK and HillCS. (2015). A temporal window for signal activation dictates the dimensions of a Nodal signaling domain. Dev Cell, 35:175–185.
39.
MüllerP, RogersKW, JordanBM, LeeJS, RobsonD, RamanathanS and SchierAF. (2012). Differential diffusivity of Nodal and Lefty underlies a reaction-diffusion patterning system. Science, 336:721–724.
40.
MarjoramL and WrightC. (2011). Rapid differential transport of Nodal and Lefty on sulfated proteoglycan-rich extracellular matrix regulates left-right asymmetry in Xenopus. Development, 138:475–485.
41.
ChenC and ShenMM. (2004). Two modes by which Lefty proteins inhibit nodal signaling. Cur Biol, 14:618–624.
42.
BillingtonCJJr, FiebigJE, ForsmanCL, PhamL, BurbachN, SunM, JaskollT, ManskyK, GopalakrishnanR, et al. (2011). Glycosylation of twisted gastrulation is required for BMP binding and activity during raniofacial development. Front Physiol, 2:59.
VarelasX, BouchieMP and KukuruzinskaMA. (2014). Protein N-glycosylation in oral cancer: dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signaling. Glycobiol, 24:579–591.
45.
HasehiraK, TatenoH, OnumaY, ItoY, AsashimaM and HirabayashiJ. (2012). Structural and quantitative evidence for dynamic glycome shift on production of induced pluripotent stem cells. Mol Cell Proteomics, 11:1913–1923.
46.
MenoC, ShimonoA, SaijohY, YashiroK, MochidaK, OhishiS, NojiS, KondohH and HamadaH. (1998). Lefty-1 is Required for Left-Right determination as a regulator of lefty-2 and nodal. Cell, 94:287–297.
47.
MenoM, TakeuchiJ, SakumaR, Koshiba-TakeuchiK, OhishiS, SaijohY, MiyazakiJ, Ten DijkeP, OguraT and HamadaH. (2001) Diffusion of Nodal signaling activity in the absence of the feedback inhibitor Lefty2. Dev Cell, 1:127–138.
48.
TopczewskaJM, PostovitLM, MargaryanNV, SamA, HessAR, WheatonWW, NickoloffBJ, TopczewskiJ and HendrixMJC. (2006). Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med, 12:925–932.
49.
HardyKM, StrizziL, MargaryanNV, GuptaK, MurphyGF, ScolyerRA and HendrixMJC. (2015). Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma. Mol Cancer Res, 13:670–680.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
